TGFB1 and neoplasm: It is therefore not surprising that this effector is dominant in the plasma and cancer cell line data, supporting the current role of TGFβ as it elicits a variety of responses relevant to cancer processes (proliferation, apotosis, inflammation, angiogenesis, autorcrine-regulation of tumor microenvironment/ECM and adhesion, invasion, and metastasis).